Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03407352 · ClinicalTrials.gov registry record · NA

Response Inhibition to High Calorie Food Cues Among Adolescents Following Active and Sedentary Video Game Play

A NA study of Obesity, sponsored by Brigham Young University.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT03407352: Completed NA study of Obesity, sponsored by Brigham Young University.

NCT03407352 is a NA study of Obesity that has completed, run by Brigham Young University. The registered enrollment target is 65 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03407352, a NA study of Obesity, has completed, sponsored by Brigham Young University.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

Response inhibition is a cognitive process that helps individuals suppress or avoid unwanted actions and inappropriate behavior. In regards to food, response inhibition allows a person to resist eating, ignore poor food choices and poor behavior related to food choices. Previous research suggests that physical activity may play a role in the regulation of response inhibition to food in adults. The purpose of this study is to compare the effects of an acute bout of active video gaming versus passive video gaming on response inhibition to high calorie and low calorie food images among adolescents. The proposed study is a randomized cross-over study with counterbalanced design. Participants will come to the lab two times. Each subject will serve as their own control. There will be two conditions and all participants will complete both conditions. One condition will be completed each time the participants come to the lab. The two conditions will include (a) 60 minutes of sedentary video game play and (b) 60 minutes of active video game play at moderate-intense levels. After each video game condition the participants will view pictures of high-calorie and low-calorie foods while being connected to an EEG machine. The EEG will measure the N2 and P3 event-related potentials, which will be used to index and analyze response inhibition. As participants view the pictures of high-calorie and low-calorie foods, they will be given a button pressing task where the press a button when they see pictures of the high-calorie or low-calorie foods. Immediately after each video game session participants will complete two cognitive measurement tasks. These tasks are (a) Stroop color-word task and (b) auditory verbal learning test. The Stroop color-word test requires the participants to read words typed in different colors on a sheet of paper and to say the name of the color of ink the words are printed in (ie to say "blue" when the word "red" is printed in blue ink). The auditory verba

Conditions Studied

Interventions

  • BEHAVIORAL Active Video Game Play
  • BEHAVIORAL Passive Video Game Play

Study Locations (1)

Utah

  • Health and Human Performance Research Center - Provo

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2016-06
Est. Completion 2017-10
Phase NA

Sponsor

Brigham Young University

10 total trials

What the Registry Record Tells You About NCT03407352

The ClinicalTrials.gov registry entry for NCT03407352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The listed sponsor is Brigham Young University, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Active Video Game Play is the first listed.

NCT03407352 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT03407352 about?

NCT03407352 is a clinical study titled "Response Inhibition to High Calorie Food Cues Among Adolescents Following Active and Sedentary Video Game Play". Response inhibition is a cognitive process that helps individuals suppress or avoid unwanted actions and inappropriate behavior. In regards to food, response inhibition allows a person to resist eating, ignore poor food choices and poor behavior related to food choices. Previous research suggests th...

What is the current status of trial NCT03407352?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2016-06. Estimated completion is 2017-10.

What conditions does trial NCT03407352 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03407352?

The interventions under investigation include: Active Video Game Play (BEHAVIORAL), Passive Video Game Play (BEHAVIORAL).

Who is sponsoring clinical trial NCT03407352?

This trial is sponsored by Brigham Young University, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03407352 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.